154 related articles for article (PubMed ID: 15764027)
21. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart.
Bartunek J; Dimmeler S; Drexler H; Fernández-Avilés F; Galinanes M; Janssens S; Martin J; Mathur A; Menasche P; Priori S; Strauer B; Tendera M; Wijns W; Zeiher A;
Eur Heart J; 2006 Jun; 27(11):1338-40. PubMed ID: 16543252
[TBL] [Abstract][Full Text] [Related]
22. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
Schannwell CM
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
[TBL] [Abstract][Full Text] [Related]
23. Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.
Oettgen P; Boyle AJ; Schulman SP; Hare JM
Circulation; 2006 Jul; 114(4):353-8. PubMed ID: 16864740
[No Abstract] [Full Text] [Related]
24. Launching a clinical program of stem cell therapy for cardiovascular repair.
Sánchez PL; Sánchez-Guijo FM; Villa A; del Cañizo C; Arnold R; San Román JA; Fernández-Avilés F
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S123-9. PubMed ID: 17230210
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function.
Di Pasquale E; Latronico MV; Jotti GS; Condorelli G
Gene Ther; 2012 Jun; 19(6):642-8. PubMed ID: 22378345
[TBL] [Abstract][Full Text] [Related]
26. The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease.
Kim J; Shapiro L; Flynn A
Pharmacol Ther; 2015 Jul; 151():8-15. PubMed ID: 25709098
[TBL] [Abstract][Full Text] [Related]
27. Regenerative therapy for cardiovascular disease.
Pfister O; Della Verde G; Liao R; Kuster GM
Transl Res; 2014 Apr; 163(4):307-20. PubMed ID: 24378637
[TBL] [Abstract][Full Text] [Related]
28. Chemical and physical regulation of stem cells and progenitor cells: potential for cardiovascular tissue engineering.
Huang NF; Lee RJ; Li S
Tissue Eng; 2007 Aug; 13(8):1809-23. PubMed ID: 17518703
[TBL] [Abstract][Full Text] [Related]
29. Cell therapy for cardiovascular disease: what cells, what diseases and for whom?
Caplice NM; Gersh BJ; Alegria JR
Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):37-43. PubMed ID: 16265341
[TBL] [Abstract][Full Text] [Related]
30. [Stem cells for the treatment of cardiovascular diseases. An update].
Bartolucci J; Verdugo FJ; Larrea R; Carrión F; Lamich R; Pedreros P; Delgado M; Sanhueza P; Khoury M; Figueroa FE
Rev Med Chil; 2014 Aug; 142(8):1034-46. PubMed ID: 25424676
[TBL] [Abstract][Full Text] [Related]
31. [Application of new vascular regenerative therapy using autologous bone marrow cells for intractable cardiovascular diseases].
Miyamoto M; Yasutake M; Takano H; Takagi H; Takagi H; Mizuno H; Kumita S; Raku M; Sakamoto A; Takano T
Masui; 2003 Dec; 52 Suppl():S67-75. PubMed ID: 14870566
[No Abstract] [Full Text] [Related]
32. Delivery of growth factor-based therapeutics in vascular diseases: Challenges and strategies.
Xu HL; Yu WZ; Lu CT; Li XK; Zhao YZ
Biotechnol J; 2017 May; 12(5):. PubMed ID: 28296342
[TBL] [Abstract][Full Text] [Related]
33. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update.
Napoli C; Hayashi T; Cacciatore F; Casamassimi A; Casini C; Al-Omran M; Ignarro LJ
Atherosclerosis; 2011 Mar; 215(1):9-22. PubMed ID: 21126740
[TBL] [Abstract][Full Text] [Related]
34. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
[TBL] [Abstract][Full Text] [Related]
35. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells.
Wu KH; Liu YL; Zhou B; Han ZC
Eur J Cardiothorac Surg; 2006 Nov; 30(5):770-81. PubMed ID: 16963271
[TBL] [Abstract][Full Text] [Related]
36. Progress and prospects: cell based regenerative therapy for cardiovascular disease.
de Muinck ED; Thompson C; Simons M
Gene Ther; 2006 Apr; 13(8):659-71. PubMed ID: 16319948
[TBL] [Abstract][Full Text] [Related]
37. In vivo tracking in cardiac stem cell-based therapy.
Hoshino K; Ly HQ; Frangioni JV; Hajjar RJ
Prog Cardiovasc Dis; 2007; 49(6):414-20. PubMed ID: 17498521
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological approaches to regenerative strategies for the treatment of cardiovascular diseases.
Pucéat M
Curr Opin Pharmacol; 2008 Apr; 8(2):189-92. PubMed ID: 18222729
[TBL] [Abstract][Full Text] [Related]
39. [A new philosophy on stem cell trials in cardiovascular diseases: to collect pollen or to be a beekeeper].
Alat I
Anadolu Kardiyol Derg; 2005 Jun; 5(2):150. PubMed ID: 15939697
[No Abstract] [Full Text] [Related]
40. Early translation of adipose-derived cell therapy for cardiovascular disease.
Sanz-Ruiz R; Fernández-Santos E; Domínguez-Muñoa M; Parma R; Villa A; Fernández L; Sánchez PL; Fernández-Avilés F
Cell Transplant; 2009; 18(3):245-54. PubMed ID: 19558773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]